Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 152

1.

Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry.

Behr J, Kreuter M, Hoeper MM, Wirtz H, Klotsche J, Koschel D, Andreas S, Claussen M, Grohé C, Wilkens H, Randerath W, Skowasch D, Meyer FJ, Kirschner J, Gläser S, Herth FJ, Welte T, Huber RM, Neurohr C, Schwaiblmair M, Kohlhäufl M, Höffken G, Held M, Koch A, Bahmer T, Pittrow D.

Eur Respir J. 2015 Apr 2. pii: ERJ-02176-2014. [Epub ahead of print]

2.

One-year safety and quality of life outcomes in patients with atrial fibrillation on dronedarone: prospective, non-interventional study in German ambulatory care.

Goette A, Benninger G, Pittrow D, Paar WD, von Stritzky B, Bosch RF.

Herzschrittmacherther Elektrophysiol. 2015 Mar 8. [Epub ahead of print]

PMID:
25750090
3.

[Psychiatric and Social Aspects of Patients with Fragile X Syndrome.]

Pittrow D, Gaese F, Colla M, Huss M, Kretschmar C, Brinkman M, Peters H, Elstner S, Weirich S, Häßler F.

Psychiatr Prax. 2015 Feb 2. [Epub ahead of print] German.

PMID:
25643039
4.

Investigating significant health trends in idiopathic pulmonary fibrosis (INSIGHTS-IPF): rationale, aims and design of a nationwide prospective registry.

Behr J, Hoeper MM, Kreuter M, Klotsche J, Wirtz H, Pittrow D.

BMJ Open Respir Res. 2014 Jan 3;1(1):e000010. doi: 10.1136/bmjresp-2013-000010. eCollection 2014. Erratum in: BMJ Open Respir Res. 2014;1(1):e000010corr1.

5.

Management and outcomes of patients with reduced ejection fraction after acute myocardial infarction in cardiac rehabilitation centers.

Reibis R, Jannowitz C, Halle M, Pittrow D, Gitt A, Völler H.

Curr Med Res Opin. 2015 Feb;31(2):211-9. doi: 10.1185/03007995.2014.977854. Epub 2014 Oct 29.

PMID:
25325219
6.

1-Year outcomes of hypertension management in 13,000 outpatients under practice conditions: prospective 3A registry.

Zeymer U, Dechend R, Riemer T, Kaiser E, Senges J, Pittrow D, Schmieder RE; 3A Registry Investigators.

Int J Cardiol. 2014 Oct 20;176(3):589-94. doi: 10.1016/j.ijcard.2014.07.089. Epub 2014 Aug 1.

PMID:
25305705
7.

The impact of age on the benefits and risks of aliskiren treatment: analyses of the 3A registry.

Friedrich S, Zeymer U, Dechend R, Hagedorn I, Riemer T, Zemmrich C, Bramlage P, Pittrow D, Senges J, Schmieder RE.

J Hum Hypertens. 2015 May;29(5):316-23. doi: 10.1038/jhh.2014.86. Epub 2014 Oct 2.

PMID:
25273857
8.

Response to letters regarding article, "Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)".

Olsson KM, Delcroix M, Ghofrani HA, Tiede H, Huscher D, Speich R, Grünig E, Staehler G, Rosenkranz S, Halank M, Held M, Lange TJ, Behr J, Klose H, Claussen M, Ewert R, Opitz CF, Vizza CD, Scelsi L, Vonk-Noordegraaf A, Kaemmerer H, Gibbs JS, Coghlan G, Pepke-Zaba J, Schulz U, Gorenflo M, Pittrow D, Hoeper MM.

Circulation. 2014 Sep 16;130(12):e110-2. doi: 10.1161/CIRCULATIONAHA.114.010921. No abstract available.

PMID:
25223780
9.

Demographics, clinical characteristics, health resource utilization and cost of chronic thromboembolic pulmonary hypertension patients: retrospective results from six European countries.

Schweikert B, Pittrow D, Vizza CD, Pepke-Zaba J, Hoeper MM, Gabriel A, Berg J, Sikirica M.

BMC Health Serv Res. 2014 Jun 9;14:246. doi: 10.1186/1472-6963-14-246.

10.

Management of patients with ST-segment elevation or non-ST-segment elevation acute coronary syndromes in cardiac rehabilitation centers.

Reibis R, Völler H, Gitt A, Jannowitz C, Halle M, Pittrow D, Hildemann S.

Clin Cardiol. 2014 Apr;37(4):213-21.

PMID:
24847509
11.

Management of patients with atrial fibrillation by primary-care physicians in Germany: 1-year results of the ATRIUM registry.

Kirchhof P, Schmalowsky J, Pittrow D, Rosin L, Kirch W, Wegscheider K, Meinertz T; ATRIUM Study Group.

Clin Cardiol. 2014 May;37(5):277-84. doi: 10.1002/clc.22272. Epub 2014 Mar 20.

PMID:
24652779
12.

Improved detection of paroxysmal atrial fibrillation utilizing a software-assisted electrocardiogram approach.

Schaefer JR, Leussler D, Rosin L, Pittrow D, Hepp T.

PLoS One. 2014 Feb 28;9(2):e89328. doi: 10.1371/journal.pone.0089328. eCollection 2014.

13.

Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials.

Saketkoo LA, Mittoo S, Huscher D, Khanna D, Dellaripa PF, Distler O, Flaherty KR, Frankel S, Oddis CV, Denton CP, Fischer A, Kowal-Bielecka OM, LeSage D, Merkel PA, Phillips K, Pittrow D, Swigris J, Antoniou K, Baughman RP, Castelino FV, Christmann RB, Christopher-Stine L, Collard HR, Cottin V, Danoff S, Highland KB, Hummers L, Shah AA, Kim DS, Lynch DA, Miller FW, Proudman SM, Richeldi L, Ryu JH, Sandorfi N, Sarver C, Wells AU, Strand V, Matteson EL, Brown KK, Seibold JR; CTD-ILD Special Interest Group.

Thorax. 2014 May;69(5):428-36. doi: 10.1136/thoraxjnl-2013-204202. Epub 2013 Dec 24. Erratum in: Thorax. 2014 Sep;69(9):834. CTD-ILD Special Interest Group [added]; multiple investigator names added.

14.

EXPLAIN Fragile-X: an explorative, longitudinal study on the characterization, treatment pathways, and patient-related outcomes of Fragile X Syndrome.

Haessler F, Gaese F, Colla M, Huss M, Kretschmar C, Brinkman M, Schieb H, Peters H, Elstner S, Pittrow D.

BMC Psychiatry. 2013 Dec 19;13:339. doi: 10.1186/1471-244X-13-339.

15.

Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).

Olsson KM, Delcroix M, Ghofrani HA, Tiede H, Huscher D, Speich R, Grünig E, Staehler G, Rosenkranz S, Halank M, Held M, Lange TJ, Behr J, Klose H, Claussen M, Ewert R, Opitz CF, Vizza CD, Scelsi L, Vonk-Noordegraaf A, Kaemmerer H, Gibbs JS, Coghlan G, Pepke-Zaba J, Schulz U, Gorenflo M, Pittrow D, Hoeper MM.

Circulation. 2014 Jan 7;129(1):57-65. doi: 10.1161/CIRCULATIONAHA.113.004526. Epub 2013 Sep 30.

16.

Gender differences in patients with atrial fibrillation.

Bosch RF, Pittrow D, Beltzer A, Kruck I, Kirch W, Kohlhaussen A, Bonnemeier H.

Herzschrittmacherther Elektrophysiol. 2013 Sep;24(3):176-83. doi: 10.1007/s00399-013-0283-5. Epub 2013 Aug 27.

PMID:
23979564
17.

Types and outcomes of cardioversion in patients admitted to hospital for atrial fibrillation: results of the German RHYTHM-AF Study.

Gitt AK, Smolka W, Michailov G, Bernhardt A, Pittrow D, Lewalter T.

Clin Res Cardiol. 2013 Oct;102(10):713-23. doi: 10.1007/s00392-013-0586-x. Epub 2013 Jun 30.

PMID:
23812041
18.

[Pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation].

Kaemmerer H, Gorenflo M, Hoeper M, Huscher D, Ewert P, Pittrow D.

Dtsch Med Wochenschr. 2013 Jun;138(23):1247-52. doi: 10.1055/s-0033-1343189. Epub 2013 May 29. Review. German.

PMID:
23720182
19.

Treatment patterns, risk factor control and functional capacity in patients with cardiovascular and chronic kidney disease in the cardiac rehabilitation setting.

Völler H, Gitt A, Jannowitz C, Karoff M, Karmann B, Pittrow D, Reibis R, Hildemann S.

Eur J Prev Cardiol. 2014 Sep;21(9):1125-33. doi: 10.1177/2047487313482285. Epub 2013 Mar 18.

PMID:
23508927
20.

Lipid management in 13,000 high risk cardiovascular patients treated under daily practice conditions: LIMA Registry.

Schaefer JR, Gitt AK, Sonntag F, Weizel A, Jannowitz C, Karmann B, Pittrow D, Bestehorn K.

Vasc Health Risk Manag. 2013;9:71-80. doi: 10.2147/VHRM.S37143. Epub 2013 Feb 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk